Changsheng Ma

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink et al. · Nature Medicine · 2022 · 814 citations · Full text

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan et al. · New England Journal of Medicine · 2024 · 530 citations · Full text

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Riccardo Cappato, Francis E. Marchlinski, Stefan H. Hohnloser et al. · European Heart Journal · 2015 · 426 citations · Full text

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein et al. · European Heart Journal · 2014 · 365 citations

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 316 citations

Metabolic Syndrome, Glucose Tolerance, Diabetes Management +10